drugset / Trial / NCT00368290

Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior

NCT00368290

Phase 2 Completed 94 enrolled Kyle Kampman
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of study is to determine if modafinil promotes cocaine abstinence and reduces high risk behavior in cocaine dependent subjects.

Timeline

Start
2006-09
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 300 mg

Indications